NCT00093496 2014-05-20Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity CancerNational Cancer Institute (NCI)Phase 2 Completed29 enrolled 9 charts